Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-21

FDA Approved: ACANYA — Supplemental Application (Bausch Health US, LLC)

View source ↗

Summary

FDA approved a supplemental application for ACANYA (clindamycin phosphate and benzoyl peroxide) by Bausch Health US, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACANYA (CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE)

Snippet

SUPPL AP for ACANYA (CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE)